An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation
At ISPOR Europe 2025, Quinten Health introduced an AI-powered tool, a deliverable of the More-EUROPA consortium, designed to make real-world data discovery faster, smarter, and more transparent, supporting regulators, HTA bodies, and researchers to identify, assess, and select fit-for-use registries for evidence generation across the drug and product development lifecycles. Leveraging AI to Identify and […]
An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation
Event: ISPOR Europe 2025, Glasgow, Scotland, UK Authors: Ghinwa Y. Hayek, Boris Kopin, Sonia Zebachi, Gaëtan Pinon, Basile Ferry, Elisabeth Bakker, Alexandre Macquin, Sieta T. de Vries, Peter G.M. Mol, Billy Amzal View Poster OBJECTIVES Selecting appropriate real-world data (RWD) sources, particularly registries, is a primary challenge for academia, industry, regulators, and health technology assessment (HTA) […]
An AI powered tool to identify and assess fit-for use registries for real-world evidence
Event: EuroDURG 2025, Uppsala, Sweden Authors: Ghinwa Y. Hayek, Pascal Godbillot, Coriande Clemente, Sonia Zebachi, Gaëtan Pinon, Boris Kopin, Elisabeth Bakker, Sieta T. de Vries, Peter G.M. Mol, Billy Amzal View publication Abstract The selection of appropriate real-world data (RWD) sources, particularly registries, is of primary concern for academia, industry, regulators, and health technology assessment […]
